Therefore, it is predicted that factors other than genetic alterations may also affect the process of the development of BilIN and cholangiocarcinoma.S100P is a molecule that is highly expressed by perihilar and extrahepatic cholangiocarcinoma as well as pancreatic ductal adenocarcinoma [9, 14].